Paul Napoli Appointed to Leadership Role in the New York Opioid Cost Recovery Litigation
October 02, 2017 07:30 ET
|
Napoli Shkolnik PLLC
NEW YORK, NY--(Marketwired - October 02, 2017) - Napoli Shkolnik PLLC is proud to announce that Paul Napoli was named Co-Lead Counsel in the New York Opioid Cost Recovery Litigation by Judge Jerry...
Portland Taps Napoli Shkolnik To Join Nationwide Opioid Lawsuit
September 20, 2017 07:30 ET
|
Napoli Shkolnik PLLC
NEW YORK, NY--(Marketwired - September 20, 2017) - Maine's largest city selected the New York City-based litigation firm to help offset the "massive damages" that the heroin addiction epidemic has...
Mora County Files Lawsuit Seeking Damages Against Manufacturers and Distributors of Opioids
August 31, 2017 15:20 ET
|
Napoli Shkolnik PLLC
MORA, NM--(Marketwired - August 31, 2017) - Mora County has become the first New Mexico governmental entity to seek damages against the manufacturers and distributors of opioid painkillers.Mora County...
UPDATE - Schuyler County Joins Growing List of New York Counties Against Opioids
August 16, 2017 16:43 ET
|
Napoli Shkolnik PLLC
WATKINS GLEN, NY--(Marketwired - August 16, 2017) - Schuyler County has become the latest New York State county to take action against the manufacturers and distributors of opioid pain killers.The...
Schuyler County Joins Growing List of New York Counties Against Opioids
August 16, 2017 15:27 ET
|
Napoli Shkolnik PLLC
WATKINS GLEN, NY--(Marketwired - August 16, 2017) - Schuyler County has become the latest New York State county to take action against the manufacturers and distributors of opioid pain killers.The...
Napoli Shkolnik PLLC Files Lawsuit Against Opioid Manufacturers and Distributors on Behalf of the City of Parma, Ohio
August 11, 2017 14:52 ET
|
Napoli Shkolnik PLLC
NEW YORK, NY--(Marketwired - August 11, 2017) - The City of Parma, Ohio has become the latest Ohio city to take action against the manufacturers and distributors of opioid pain medications for their...
Issue Brief Explores the Many Facets of Opioid Abuse
September 14, 2016 07:33 ET
|
The Center for Health Affairs
CLEVELAND, Sept. 14, 2016 (GLOBE NEWSWIRE) -- The Center for Health Affairs' August 2016 Issue Brief, A Growing Epidemic: Battling Opioid Abuse in Ohio, explores the many facets of the opioid abuse...
Lightlake Therapeutics Inc.Announces Adapt Pharma Limited to Offer All U.S. High Schools a Free Narcan® (Naloxone Hydrochloride) Nasal Spray and Fund School-Based Opioid Overdose Education
January 27, 2016 09:00 ET
|
Opiant Pharmaceuticals, Inc.
NEW YORK, Jan. 27, 2016 (GLOBE NEWSWIRE) -- Lightlake Therapeutics Inc. (“Lightlake”) (OTCQB:LLTP), a specialty pharmaceutical company developing pharmacological treatments for substance use,...
Lightlake Therapeutics Inc. Announces Adapt Pharma Limited Facilitates NARCAN® (Naloxone Hydrochloride) Nasal Spray Access to 62,000 State and Local Public Entities
January 19, 2016 09:00 ET
|
Opiant Pharmaceuticals, Inc.
NEW YORK, Jan. 19, 2016 (GLOBE NEWSWIRE) -- Lightlake Therapeutics Inc. (“Lightlake”) (OTCQB:LLTP), a specialty pharmaceutical company developing pharmacological treatments for substance use,...
Lightlake Therapeutics Inc. Receives Milestone Payment for U.S. Food and Drug Administration Approval of NARCAN(R) (Naloxone Hydrochloride) Nasal Spray
December 15, 2015 09:00 ET
|
Opiant Pharmaceuticals, Inc.
NEW YORK, Dec. 15, 2015 (GLOBE NEWSWIRE) -- Lightlake Therapeutics Inc. (“Lightlake”) (OTCQB:LLTP), a specialty pharmaceutical company developing pharmacological treatments for substance use,...